Post by PLU Ophthalmic

751 followers

For decades, glaucoma surgeons have had to choose between two imperfect options.​ ​ MIGS: minimal risk, but limited IOP reduction in moderate-to-advanced disease. ​ Trabeculectomy: effective, but surgically complex with high postoperative burden.​ ​ There was always a gap between them.​ AquaLumen™ was built to close it.​ ​ Implant-free. Conjunctiva-sparing. Filtration-level IOP control — through a standardized ab externo approach that changes where subconjunctival filtration fits in the treatment algorithm.​ ​ 🎯 Watch to see how it works.​ 🔗 Full white paper at Aqualumen.net | Link in bio​ ​ #AquaLumen #GlaucomaSurgery #Ophthalmology #MedTech #GlaucomaInnovation #SubconjunctivalFiltration #ImplantFree #MIGS #GlaucomaCare​

Post content

Video Content